MVP logo

Medical Developments International Limited Stock Price

ASX:MVP Community·AU$75.5m Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author

MVP Share Price Performance

AU$0.67
0.22 (48.89%)
70.4% undervalued intrinsic discount
AU$2.27
Fair Value
AU$0.67
0.22 (48.89%)
71.1% undervalued intrinsic discount
AU$2.32
Fair Value
Price AU$0.67
AnalystConsensusTarget AU$2.32
AnalystLowTarget AU$0.80

MVP Community Narratives

AnalystConsensusTarget·
Fair Value AU$2.27 72.4% undervalued intrinsic discount

European Approvals And Distribution Partnerships Will Expand Global Reach

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AnalystLowTarget·
Fair Value AU$0.8 21.9% undervalued intrinsic discount

European Delays And Tariff Pressures Will Weigh As Potential Emerges

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent MVP News & Updates

There Is A Reason Medical Developments International Limited's (ASX:MVP) Price Is Undemanding

Aug 08
There Is A Reason Medical Developments International Limited's (ASX:MVP) Price Is Undemanding

Medical Developments International (ASX:MVP) Is In A Strong Position To Grow Its Business

Jul 18
Medical Developments International (ASX:MVP) Is In A Strong Position To Grow Its Business
User avatar

Targeted Pricing And Penthrox Expansion Will Broaden International Reach

Targeted pricing and efficiency programs are improving margins, expected to enhance earnings and net margins over the next few years.

Medical Developments International Limited (ASX:MVP) Held Back By Insufficient Growth Even After Shares Climb 33%

May 07
Medical Developments International Limited (ASX:MVP) Held Back By Insufficient Growth Even After Shares Climb 33%

Medical Developments International (ASX:MVP) Is In A Strong Position To Grow Its Business

Apr 18
Medical Developments International (ASX:MVP) Is In A Strong Position To Grow Its Business

Take Care Before Jumping Onto Medical Developments International Limited (ASX:MVP) Even Though It's 27% Cheaper

Mar 16
Take Care Before Jumping Onto Medical Developments International Limited (ASX:MVP) Even Though It's 27% Cheaper

Medical Developments International Limited Key Details

AU$39.1m

Revenue

AU$9.6m

Cost of Revenue

AU$29.4m

Gross Profit

AU$29.3m

Other Expenses

AU$94.0k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.00083
Gross Margin
75.35%
Net Profit Margin
0.24%
Debt/Equity Ratio
0%

Medical Developments International Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and undervalued.

1 Risk
4 Rewards

About MVP

Founded
1972
Employees
n/a
CEO
Brent MacGregor
WebsiteView website
medicaldev.com

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Australian Market Performance

  • 7 Days: 0.4%
  • 3 Months: 5.4%
  • 1 Year: 8.9%
  • Year to Date: 9.7%
Over the last 7 days, the market has remained flat, although notably the Materials sector gained 3.8% in that time. As for the longer term, the market has risen 8.9% in the past 12 months. Earnings are forecast to grow by 12% annually. Market details ›